NCT01049802View on ClinicalTrials.gov

Contrastim Stroke Trial

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

September 30, 2016

Conditions

Stroke

Interventions

DEVICE

Repetititve transcranial magnetic stimulation

1 Hz rTMS to contralesional hemisphere in patients with stroke

Trial Locations (1)

60611

The Rehabilitation Institute of Chicago, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Nexstim Ltd

INDUSTRY

lead

Shirley Ryan AbilityLab

OTHER

NCT01049802 - Contrastim Stroke Trial | Biotech Hunter | Biotech Hunter